pubmed-article:7776775 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7776775 | lifeskim:mentions | umls-concept:C0018821 | lld:lifeskim |
pubmed-article:7776775 | lifeskim:mentions | umls-concept:C1522564 | lld:lifeskim |
pubmed-article:7776775 | lifeskim:mentions | umls-concept:C1545588 | lld:lifeskim |
pubmed-article:7776775 | lifeskim:mentions | umls-concept:C1291208 | lld:lifeskim |
pubmed-article:7776775 | pubmed:issue | 8949 | lld:pubmed |
pubmed-article:7776775 | pubmed:dateCreated | 1995-7-7 | lld:pubmed |
pubmed-article:7776775 | pubmed:abstractText | A low myocardial content of alpha-ketoglutarate during heart surgery might aggravate ischaemic injury. 24 men undergoing coronary surgery participated in a randomised controlled study. 28 g alpha-ketoglutarate was added to blood cardioplegia for intermittent antegrade intracoronary perfusion in 13 cases. alpha-ketoglutarate reduced the appearance in blood of the ischaemic markers creatine kinase MB and troponin T (at 4 h after release of aortic cross-clamp; median [95% CI] 49 [37-60] micrograms/L in controls vs 32 [27-37] micrograms/L for creatine kinase MB, 2.0 [1.2-2.8] vs 1.1 [0.8-1.4] micrograms/L for troponin T). These findings signify attenuated ischaemic injury, possibly secondary to enhanced myocardial oxidative capacity. | lld:pubmed |
pubmed-article:7776775 | pubmed:language | eng | lld:pubmed |
pubmed-article:7776775 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7776775 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7776775 | pubmed:month | Mar | lld:pubmed |
pubmed-article:7776775 | pubmed:issn | 0140-6736 | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:JagenburgRR | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:SvenssonGG | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:NilssonFF | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:KarlssonHH | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:EkrothRR | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:WernermanJJ | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:BjörkKK | lld:pubmed |
pubmed-article:7776775 | pubmed:author | pubmed-author:KjellmanUU | lld:pubmed |
pubmed-article:7776775 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7776775 | pubmed:day | 4 | lld:pubmed |
pubmed-article:7776775 | pubmed:volume | 345 | lld:pubmed |
pubmed-article:7776775 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7776775 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7776775 | pubmed:pagination | 552-3 | lld:pubmed |
pubmed-article:7776775 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:meshHeading | pubmed-meshheading:7776775-... | lld:pubmed |
pubmed-article:7776775 | pubmed:year | 1995 | lld:pubmed |
pubmed-article:7776775 | pubmed:articleTitle | Alpha-ketoglutarate for myocardial protection in heart surgery. | lld:pubmed |
pubmed-article:7776775 | pubmed:affiliation | Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg, Sweden. | lld:pubmed |
pubmed-article:7776775 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7776775 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7776775 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |